The condition itself, not the weight, is driving the risk
For generations, heart disease risk in women has been mapped largely onto weight and metabolic disorder — but a sweeping Nordic study of more than 127,000 women with polycystic ovary syndrome is quietly redrawing that map. Across Denmark, Finland, and Sweden, women with PCOS carried a 32 to 48 percent greater likelihood of developing cardiovascular disease, and the sharpest surprise came from those medicine had long considered safe: normal-weight women without diabetes faced a 40 percent elevation in risk. The findings suggest that hormonal imbalance itself — not merely its outward consequences — may be quietly straining the heart, and that medicine's habit of equating visible vulnerability with actual danger has left many women unguarded.
- A decade-long study of 127,517 women has shattered the assumption that normal weight protects PCOS patients from heart disease, revealing a 40% elevated cardiovascular risk even in the absence of obesity or diabetes.
- Excess testosterone — the hormonal hallmark of PCOS — appears to constrict blood vessels and raise blood pressure independently of weight, suggesting the condition itself is the threat, not just its metabolic side effects.
- The risk held firm across three countries, with Finland showing the steepest elevation at 48.6%, signaling this is not a statistical anomaly but a consistent, cross-national pattern.
- Current clinical practice treats PCOS primarily as a fertility and metabolic condition, leaving cardiovascular danger largely unscreened in women who don't fit the traditional high-risk profile.
- Researchers are now calling for PCOS to be stratified into distinct risk categories, with personalized cardiovascular screening plans that follow women well beyond their reproductive years.
A major study spanning three Nordic countries has overturned a long-held assumption in women's medicine: that heart disease risk in polycystic ovary syndrome is driven primarily by weight. Tracking more than 127,000 women with PCOS over ten years, researchers found a 32 percent overall increase in cardiovascular risk compared to women without the condition — but the most unsettling discovery involved those considered low-risk. Normal-weight women with PCOS who had no type 2 diabetes still faced a 40 percent elevation in heart disease danger.
Led by Professor Dorte Glintborg of the University of Southern Denmark and presented at the European Congress of Endocrinology in Prague, the study compared PCOS patients to nearly 588,000 women without the condition, all between ages 15 and 50. The elevated risk appeared consistently across Denmark, Finland, and Sweden, with Finland registering the highest at 48.6 percent.
The likely mechanism is hormonal. Women with PCOS carry abnormally high testosterone levels, and the research found that even normal-weight patients showed elevated blood pressure — a known cardiovascular risk factor. The theory is that excess testosterone causes blood vessels to constrict and stiffen over time, stressing the heart through a pathway entirely separate from obesity or metabolic disease.
The findings carry direct implications for clinical care. PCOS is currently managed largely around fertility and metabolic concerns, leaving cardiovascular risk underscreened in women who appear otherwise healthy. Glintborg's team is calling for a fundamental rethink: stratifying PCOS into distinct long-term risk profiles and extending care plans beyond reproductive treatment. As she put it, the goal is to give each woman a precise picture of her risk — one that doesn't end at the fertility clinic.
A large study spanning three Nordic countries has upended a common assumption about heart disease risk in women with polycystic ovary syndrome: it isn't just a problem for those carrying extra weight. Researchers following more than 127,000 women with PCOS over a decade found their heart disease risk climbed 32 percent compared to women without the condition. But the finding that startled them most came from a subset that conventional medicine often considered low-risk: normal-weight women with PCOS who didn't have type 2 diabetes faced a 40 percent elevation in cardiovascular danger.
The study, led by Professor Dorte Glintborg of the University of Southern Denmark and presented at the 28th European Congress of Endocrinology in Prague, represents the first large-scale examination of PCOS and heart disease across multiple countries. Her team compared 127,517 women diagnosed with PCOS to nearly 588,000 women without it, all between ages 15 and 50. The researchers tracked them for an average of ten years, watching how many developed heart disease. When they broke down the numbers by country, the pattern held: Denmark showed a 37.7 percent increased risk, Finland 48.6 percent, and Sweden 41.7 percent.
What makes this work distinct is its focus on women who don't fit the typical cardiovascular risk profile. Previous research on PCOS and heart disease tended to concentrate on heavier women or those with metabolic complications. "To our knowledge, our study is the first to combine results from several nationwide study cohorts and evaluate the prospective risk of cardiovascular disease in women with polycystic ovary syndrome," Glintborg said. The discovery that normal-weight women faced such elevated risk suggested something biological was at work beyond the usual culprits of obesity and diabetes.
The mechanism appears rooted in the hormonal chaos that defines PCOS. Women with the condition typically have abnormally high testosterone levels, and Glintborg's team found evidence that this excess hormone may directly stress the cardiovascular system. Normal-weight women with PCOS showed higher blood pressure than normal-weight women without it—a well-established independent risk factor for heart disease. The theory is that elevated testosterone causes blood vessels to constrict and lose flexibility, a process that over years or decades could strain the heart. This happens independently of weight gain or the development of diabetes, meaning it's the condition itself, not its metabolic complications, driving the risk.
The implications are significant for how doctors approach PCOS. Currently, the condition is often treated as a single diagnosis, with management focused primarily on fertility issues and metabolic concerns. Glintborg and her colleagues propose a fundamental shift: stratifying PCOS into distinct long-term risk profiles, some tilted toward diabetes, others toward cardiovascular disease. "In the long term, we hope to be able to give each woman a more precise picture of her risk and a plan that extends beyond the next fertility treatment," she said. That would mean regular cardiovascular screening for all women with PCOS, not just those who appear metabolically vulnerable. It would mean recognizing that a woman at normal weight with PCOS is not, in fact, at normal risk. The study was published in the European Journal of Endocrinology.
Citações Notáveis
The fact that women with PCOS of normal weight also have an increased cardiovascular disease risk suggests that the biology of the condition itself—such as high levels of testosterone—may affect the cardiovascular system, independently of weight and type 2 diabetes.— Professor Dorte Glintborg, University of Southern Denmark
We hope to be able to give each woman a more precise picture of her risk and a plan that extends beyond the next fertility treatment.— Professor Dorte Glintborg
A Conversa do Hearth Outra perspectiva sobre a história
Why does a condition that affects the ovaries end up damaging the heart?
PCOS is fundamentally a hormonal disorder. The excess testosterone these women produce doesn't just affect reproduction—it appears to have direct effects on blood vessel function. The vessels become stiffer, less able to dilate and contract as they should, which puts chronic strain on the heart.
But couldn't weight gain from PCOS explain the heart disease risk?
That's what everyone assumed. But this study deliberately looked at normal-weight women and found the same elevated risk. That's the breakthrough. It means the hormone imbalance itself is the culprit, not the weight that sometimes comes with it.
So a thin woman with PCOS is in more danger than a thin woman without it?
Yes. And she might not know it. Most PCOS care focuses on fertility and managing blood sugar. Cardiovascular screening isn't routine. These women could be walking around with silently stiffening arteries.
What changes if doctors accept this finding?
Everything. Instead of one-size-fits-all PCOS management, you'd stratify women by their specific risks. Some need aggressive diabetes prevention. Others need aggressive heart disease prevention. Each woman gets a personalized roadmap, not just fertility treatment.
How long before a heart attack might occur?
The study followed women for ten years on average. That's when the risk became measurable. But the damage is likely accumulating silently for years before that. That's why early screening matters.
Is there a way to reverse the vessel damage?
The study doesn't address treatment. But if the mechanism is testosterone-driven vessel stiffness, then managing testosterone levels might help. That's the next question researchers need to answer.